ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,865,000 | +16.4% | 300,000 | +33.3% | 5.14% | +21.6% |
Q2 2021 | $15,345,000 | +5.3% | 225,000 | +7.1% | 4.22% | +1.4% |
Q1 2021 | $14,572,000 | -5.2% | 210,000 | +5.0% | 4.16% | -8.9% |
Q4 2020 | $15,366,000 | +37.0% | 200,000 | +33.3% | 4.57% | +33.2% |
Q3 2020 | $11,219,000 | +1.8% | 150,000 | -14.3% | 3.43% | +4.0% |
Q2 2020 | $11,016,000 | +138.4% | 175,000 | +59.1% | 3.30% | +62.1% |
Q1 2020 | $4,620,000 | +45.3% | 110,000 | +57.1% | 2.04% | +64.4% |
Q4 2019 | $3,179,000 | – | 70,000 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |